Orgogozo JM - Search Results

1

Acute stroke: trial by jury. The toothless tiger (role of the principal investigator).

Lees KR, Orgogozo JM. Lees KR, et al. Among authors: orgogozo jm. Eur Neurol. 2003;49(2):120-4. doi: 10.1159/000068512. Eur Neurol. 2003. PMID: 12584423

2

Acute Stroke Therapy by Inhibition of Neutrophils (ASTIN): an adaptive dose-response study of UK-279,276 in acute ischemic stroke.

Krams M, Lees KR, Hacke W, Grieve AP, Orgogozo JM, Ford GA; ASTIN Study Investigators. Krams M, et al. Among authors: orgogozo jm. Stroke. 2003 Nov;34(11):2543-8. doi: 10.1161/01.STR.0000092527.33910.89. Epub 2003 Oct 16. Stroke. 2003. PMID: 14563972 Clinical Trial.

3

Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trial. GAIN International Investigators.

Lees KR, Asplund K, Carolei A, Davis SM, Diener HC, Kaste M, Orgogozo JM, Whitehead J. Lees KR, et al. Among authors: orgogozo jm. Lancet. 2000 Jun 3;355(9219):1949-54. doi: 10.1016/s0140-6736(00)02326-6. Lancet. 2000. PMID: 10859040 Clinical Trial.

4

Tirilazad for acute ischaemic stroke.

Bath PM, Iddenden R, Bath FJ, Orgogozo JM; Tirilazad International Steering Committee. Bath PM, et al. Among authors: orgogozo jm. Cochrane Database Syst Rev. 2001;(4):CD002087. doi: 10.1002/14651858.CD002087. Cochrane Database Syst Rev. 2001. PMID: 11687138

5

European Stroke Initiative: recommendations for stroke management. Organisation of stroke care.

Hacke W, Kaste M, Olsen TS, Orgogozo JM, Bogousslavsky J. Hacke W, et al. Among authors: orgogozo jm. J Neurol. 2000 Sep;247(9):732-48. J Neurol. 2000. PMID: 11081821 No abstract available.

6

European Stroke Initiative (EUSI) recommendations for stroke management. The European Stroke Initiative Writing Committee.

Hacke W, Kaste M, Skyhoj Olsen T, Orgogozo JM, Bogousslavsky J. Hacke W, et al. Among authors: orgogozo jm. Eur J Neurol. 2000 Nov;7(6):607-23. doi: 10.1046/j.1468-1331.2000.00137.x. Eur J Neurol. 2000. PMID: 11136346

7

MRI of acute brainstem ischaemia: cytotoxic versus vasogenic oedema?

Sibon I, Menegon P, Rouanet F, Dousset V, Orgogozo JM. Sibon I, et al. Among authors: orgogozo jm. Eur J Neurol. 2004 Jul;11(7):497-8. doi: 10.1111/j.1468-1331.2004.00847.x. Eur J Neurol. 2004. PMID: 15257692 No abstract available.

8

The effect of tirilazad mesylate on infarct volume of patients with acute ischemic stroke.

van der Worp HB, Kappelle LJ, Algra A, Bär PR, Orgogozo JM, Ringelstein EB, Bath PM, van Gijn J; TESS Investigators; TESS II Investigators. van der Worp HB, et al. Among authors: orgogozo jm. Neurology. 2002 Jan 8;58(1):133-5. doi: 10.1212/wnl.58.1.133. Neurology. 2002. PMID: 11781420 Clinical Trial.

9

Endpoints for trials in Alzheimer's disease: a European task force consensus.

Vellas B, Andrieu S, Sampaio C, Coley N, Wilcock G; European Task Force Group. Vellas B, et al. Lancet Neurol. 2008 May;7(5):436-50. doi: 10.1016/S1474-4422(08)70087-5. Lancet Neurol. 2008. PMID: 18420157 Review.

10

Acute treatment of ischemic stroke. European Stroke Initiative (EUSI).

Hacke W, Kaste M, Skyhoj Olsen T, Bogousslavsky J, Orgogozo JM. Hacke W, et al. Among authors: orgogozo jm. Cerebrovasc Dis. 2000;10 Suppl 3:22-33. doi: 10.1159/000047578. Cerebrovasc Dis. 2000. PMID: 10940667 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

189 results

Search Page

Filters